Study uses blood protein changes in memory loss and Alzheimer’s
Part of Brain & nervous system, Mental health clinical trials.
This trial studies blood “protein fingerprints” in people with mild memory problems or Alzheimer’s disease to better understand what’s happening. It may help researchers find ways to measure the condition and improve care over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 55 or older (male or female)
- Have a diagnosis of mild cognitive impairment or Alzheimer’s disease, or have a close family member diagnosed with Alzheimer’s
- Have your memory symptoms rated using the AD-8 questionnaire
- Be willing to join the research and sign informed consent
- Not have certain serious recent illnesses (like a recent stroke/heart problem or serious infections)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a simple blood test to quickly detect Alzheimer's-related brain changes (amyloid plaques). It may help people with memory concerns avoid a more invasive PET scan and get answers faster.
This study looks for brain/biological “signals” (biomarkers) that may identify Alzheimer’s disease earlier, including stages before clear symptoms. You may be followed for about 5 years, with repeated memory and thinking testing to see how these signs relate to future diagnosis.
This study looks at a specific brain pathway that may be linked to early memory loss in Alzheimer's disease. It compares people with early Alzheimer's to healthy older adults to understand how connections between brain cells start to break down.
This study is testing whether a simple blood test can help diagnose Alzheimer's disease and predict how the disease will progress. If you have memory or thinking problems that have been getting worse, you may be able to join.
This study looks at how thinking and memory change as we age. It involves tests, blood samples, and brain scans to better understand cognitive decline.
This study supports Alzheimer’s research by collecting health and thinking (cognitive) test results and blood samples to study genetics and biomarkers. You may be enrolled if you’re age 40 or older and can do these checkups, even if you have mild memory problems or dementia.
Hear when a new Alzheimer Disease, Early Onset trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.